Cormorant Private Healthcare Fund II, LP is 10% Owner at MoonLake Immunotherapeutics (MLTX). They have made 2 open-market trades across 2 companies since 2020, most recently 2023-10-05.
CIK 0001747677
2 open-market purchases totalling $12.4M since 2020, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.